findmyKOL

Joseph McEvoy, MD

Enriched profile

Case Distinguished Chair in Psychotic Disorders / Professor, Department of Psychiatry and Health Behavior · Medical College of Georgia

ORCIDNPI
Region🇺🇸 Augusta, GA · Southeast · United StatesSpecialtyPsychiatryFocusSchizophrenia
Active KOLfindmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLatest publication2025Online presenceverified 2026Payments2021–2025NIH funding2021–2025

Joseph McEvoy is Case Distinguished Chair in Psychotic Disorders / Professor, Department of Psychiatry and Health Behavior at Medical College of Georgia. OpenAlex indexes 354 publications with 30,717 citations (h-index 81); ClinicalTrials.gov lists 7 registered studies with this person as an investigator. By OpenAlex citation count, this profile ranks in the top 5% of Psychiatry profiles in the findmyKOL directory.

Data verified 14 Aug 2026

Overview

Updated 27 Aug 2026

Joseph P. McEvoy, MD, is Case Distinguished Chair in Psychotic Disorders / Professor, Department of Psychiatry and Health Behavior at Medical College of Georgia, Augusta University. The public record shows 354 publications with 30,717 citations (h-index 81), centered on Schizophrenia. It also documents an investigator role on 7 registered clinical trials, industry payments reported by 18 companies, 1 NIH-funded awards (2021–2025).

  • Most recent indexed publication: 2025 · JMIR mental health
  • Top research focus: Schizophrenia
  • 7 registered trials on ClinicalTrials.gov
  • Open Payments reporting from 18 companies

Generated from the cited public record · current as of 27 Aug 2026. Every fact links its source below.

Indications focus

from trials led + research topics
Schizophrenia7 trialsPsychotic Disorders3 trials

Research focus

OpenAlex concept fingerprint
Schizophrenia

Drugs & molecules

across trials, industry payments and publications
Aristadageneric · Aripiprazole lauroxilClinical trialsIndustry payments107PublicationsLybalvigeneric · Olanzapine / samidorphanClinical trialsIndustry payments31PublicationsCaplytageneric · LumateperoneClinical trialsIndustry payments9Publications

Works with

trial sponsors and companies reporting payments
Alkermes, Inc.Clinical trialsIndustry payments28Boehringer Ingelheim Pharmaceuticals, Inc.Clinical trialsIndustry payments13ITI, Inc.Clinical trialsIndustry payments6

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
354publications

Distinct works indexed by OpenAlex, matched via ORCID; 1 in PubMed.

30,717citations

Total citations across indexed works.

81h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
7clinical trials

Investigator role on registered studies.

View trials
18companies · 2021–2025

Companies reporting payments to CMS. Facts, not judgments.

View payments
1NIH grants · 2021–2025

Federally funded research awards.

View funding

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

Telephone

Practice address and telephone from the federal NPPES registry.

Sign in to view contact details →

Clinical trials

Updated 27 Aug 2026

Listed as an investigator on 7 registered studies on ClinicalTrials.gov. The most recent:

Industry payments

Updated 27 Aug 2026

18 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Nervous system

    81.7%
    Atypical Antipsychotic29.8%
    Clozapine33%Olanzapine27%Invega Sustenna16%Risperidone12%Aripiprazole6%Quetiapine Fumarate6%
    Part D<11 patients
    Benzodiazepine10.1%
    Clonazepam68%Diazepam17%Alprazolam16%
    Part D<11 patients
  • Metabolism & gastrointestinal

    8.1%
    Biguanide (metformin)6.9%
    Metformin Hcl Er67%Metformin Hcl33%
    Part D<11 patients
    Proton pump inhibitor1.2%
    Pantoprazole Sodium100%
    Part D<11 patients
  • Cardiovascular

    5.9%
    Beta blocker3%
    Propranolol Hcl60%Metoprolol Succinate40%
    Part D<11 patients
    Statin1.7%
    Atorvastatin Calcium100%
    Part D<11 patients
2 more therapeutic areas behind the reveal.Reveal →
Where care is delivered (Part B), 2023100% facility · 0% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

NIH funding

Updated 27 Aug 2026

1 NIH research award on record, funded 20212025 per NIH RePORTER. The latest:

Publications

Updated 27 Aug 2026

Their five most recent publications, matched to their ORCID record and linked to PubMed.

Online presence

Updated 27 Aug 2026

This person's own public accounts first, then places where others mention them. Two different things, listed separately.

Owned accounts

public accounts run by this person
  • ResearchGate

    researchgate.net/scientific-contributions/Joseph-P-McEvoy-39051005

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →researchgate.net

We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.

Background & recognition

Updated 27 Aug 2026

Credentials, appointments and honors, newest first, each linked to the public source it came from.

Education

degrees and training on record
  • Board Certified

    Psychiatry (ABPN), recertified 2016

    2016
    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →augusta.edu
  • M.D.

    Vanderbilt University

    1973
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →augusta.edu
  • B.A.

    Biology/Biological Sciences, Manhattan College

    1969
    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →augusta.edu

Editorial & leadership roles

journal and society appointments
  • Board Member

    NAMI (National Alliance on Mental Illness), 2014-Present

    2014
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →augusta.edu

Awards & honors

honors on the public record
1 more award behind the reveal.Reveal →

Secondary affiliations

appointments beyond the home institution

Media & interviews

press, podcasts and appearances

Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.

Similar KOLs

Other experts from the same institution or the same specialty.